BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA: CASE REPORT
DOI:
https://doi.org/10.56238/isevjhv5n2-001Keywords:
Anaplastic Large Cell Lymphoma, Breast Implants, Late Seroma, Implant-Associated Lymphoma, Breast NeoplasmsAbstract
Breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) is a rare T-cell neoplasm mainly related to the use of textured breast implants. It usually presents as a late periprosthetic seroma, occurring years after implant surgery. We report the case of a 45-year-old patient with a history of augmentation mammoplasty with polyurethane implants who developed a persistent late seroma. After prolonged clinical and radiological follow-up, aspiration of the periprosthetic fluid revealed CD30-positive malignant cells, confirming the diagnosis of BIA-ALCL. The patient underwent bilateral breast explantation with complete capsulectomy, with no evidence of residual neoplasia in the surgical specimens. This case highlights the importance of clinical suspicion and cytopathological analysis of periprosthetic fluid in patients with late seroma, enabling early diagnosis and appropriate treatment, with a direct impact on prognosis.
References
Sermoud, L. M. C. de O., Romano, S., Chved, M., & Amorim, G. L. da S. (2019). Breast implant–associated anaplastic large-cell lymphoma: Why must we learn about it? Journal of Global Oncology, 5, 1–5. https://doi.org/10.1200/JGO.19.00224
Vieira, R. A. da C., et al. (2020). Multidisciplinary approach in the clinical and laboratory investigation of a suspected case for anaplastic lymphoma associated with breast prosthesis. Mastology, 30, Article e20200030. https://doi.org/10.29289/25945394202020200030
Clemens, M. W., et al. (2016). Complete surgical excision is essential for the management of patients with breast implant–associated anaplastic large-cell lymphoma. Journal of Clinical Oncology, 34(2), 160–168. https://doi.org/10.1200/JCO.2015.63.3412
Ronchi, A., et al. (2018). Diagnosis of anaplastic large cell lymphoma on late peri-implant breast seroma: Management of cytological sample by an integrated approach. Cytopathology, 29(3), 254–261. https://doi.org/10.1111/cyt.12541
Real, D. S. S., & Resendes, B. S. (2019). Linfoma anaplásico de grandes células relacionado ao implante mamário: Revisão sistemática da literatura. Revista Brasileira de Cirurgia Plástica, 34(4), 531–538. https://doi.org/10.5935/2177-1235.2019RBCP0234
Mehta-Shah, N., Clemens, M. W., & Horwitz, S. M. (2018). How I treat breast implant–associated anaplastic large cell lymphoma. Blood, 132(18), 1889–1898. https://doi.org/10.1182/blood-2018-04-848382
Marra, A., et al. (2020). Breast implant-associated anaplastic large cell lymphoma: A comprehensive review. Cancer Treatment Reviews, 84, Article 101963. https://doi.org/10.1016/j.ctrv.2020.101963
Quesada, A. E., et al. (2019). Breast implant-associated anaplastic large cell lymphoma: A review. Modern Pathology, 32, 166–179. https://doi.org/10.1038/s41379-018-0134-3
Ebner, P. J., et al. (2019). Breast implant-associated anaplastic large cell lymphoma, a systematic review and in-depth evaluation of the current understanding. Journal of Surgical Oncology, 120(4), 573–580. https://doi.org/10.1002/jso.25626
